Literature DB >> 11035050

Activated murine endothelial cells have reduced immunogenicity for CD8+ T cells: a mechanism of immunoregulation?

F M Marelli-Berg1, D Scott, I Bartok, E Peek, J Dyson, R I Lechler.   

Abstract

The immunogenic properties of primary cultures of murine lung microvascular endothelial cells (EC) were analyzed. Resting endothelial cells were found to constitutively express low levels of MHC class I and CD80 molecules. IFN-gamma treatment of EC resulted in a marked up-regulation of MHC class I, but no change was observed in the level of CD80 expression. No CD86 molecules were detectable under either condition. The ability of peptide-pulsed EC to induce the proliferation of either the HY-specific, H2-K(k)-restricted CD8(+) T cell clone (C6) or C6 TCR-transgenic naive CD8(+) T cells was analyzed. Resting T cells were stimulated to divide by quiescent peptide-prepulsed EC, while peptide-pulsed, cytokine-activated EC lost the ability to induce T cell division. Furthermore, Ag presentation by cytokine-activated EC induced CD8(+) T cell hyporesponsiveness. The immunogenicity of activated EC could be restored by adding nonsaturating concentrations of anti-H2-K(k) Ab in the presence of an optimal concentration of cognate peptide. This is consistent with the suggestion that the ratio of TCR engagement to costimulation determines the outcome of T cell recognition. In contrast, activated peptide-pulsed EC were killed more efficiently by fully differentiated effector CD8(+) T cells. Finally, evidence is provided that Ag recognition of EC can profoundly affect the transendothelial migration of CD8(+) T cells. Taken together, these results suggest that EC immunogenicity is regulated in a manner that contributes to peripheral tolerance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035050     DOI: 10.4049/jimmunol.165.8.4182

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  A rendezvous before rejection: where do T cells meet transplant antigens?

Authors:  David M Briscoe; Mohamed H Sayegh
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

2.  An evidence for surface expression of an immunogenic epitope of sarcoplasmic/endoplasmic reticulum calcium-ATPase2a on antigen-presenting cells from naive mice in the mediation of autoimmune myocarditis.

Authors:  Rajkumar Arumugam; Bharathi Yalaka; Chandirasegaran Massilamany; M S Shihabudeen Haider Ali; Ninaad Lasrado; Sabarirajan Jayaraja; Jean-Jack Riethoven; Xinghui Sun; Jay Reddy
Journal:  Immunobiology       Date:  2019-12-13       Impact factor: 3.144

3.  Novel Application of Localized Nanodelivery of Anti-Interleukin-6 Protects Organ Transplant From Ischemia-Reperfusion Injuries.

Authors:  Z Solhjou; M Uehara; B Bahmani; O H Maarouf; T Ichimura; C R Brooks; W Xu; M Yilmaz; A Elkhal; S G Tullius; I Guleria; M M McGrath; R Abdi
Journal:  Am J Transplant       Date:  2017-04-18       Impact factor: 8.086

4.  Nanodelivery of Mycophenolate Mofetil to the Organ Improves Transplant Vasculopathy.

Authors:  Mayuko Uehara; Baharak Bahmani; Liwei Jiang; Sungwook Jung; Naima Banouni; Vivek Kasinath; Zhabiz Solhjou; Jing Zhao; Farideh Ordikhani; Munhyung Bae; Nasim Annabi; Martina M McGrath; Reza Abdi
Journal:  ACS Nano       Date:  2019-09-25       Impact factor: 15.881

5.  Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells.

Authors:  Michael J Eppihimer; Jason Gunn; Gordon J Freeman; Edward A Greenfield; Tetyana Chernova; Jamie Erickson; John P Leonard
Journal:  Microcirculation       Date:  2002-04       Impact factor: 2.628

6.  Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group.

Authors:  Gustavo Valbuena; William Bradford; David H Walker
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

7.  Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen.

Authors:  Beatrice Bolinger; Philippe Krebs; Yinghua Tian; Daniel Engeler; Elke Scandella; Simone Miller; Douglas C Palmer; Nicholas P Restifo; Pierre-Alain Clavien; Burkhard Ludewig
Journal:  Blood       Date:  2008-01-14       Impact factor: 22.113

8.  PD-1 inhibits antiviral immunity at the effector phase in the liver.

Authors:  Yoshiko Iwai; Seigo Terawaki; Masaya Ikegawa; Taku Okazaki; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

9.  Endothelial cells present antigens in vivo.

Authors:  Annette L Rothermel; Yinong Wang; Jeffrey Schechner; Barry Mook-Kanamori; William C Aird; Jordan S Pober; George Tellides; David R Johnson
Journal:  BMC Immunol       Date:  2004-03-16       Impact factor: 3.615

Review 10.  Enhancement of T cell recruitment and infiltration into tumours.

Authors:  C Oelkrug; J M Ramage
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.